Morning and welcome back to the land of the living.

Cannacord sure can put the evil eye on a stock and their sell advice put the hammer on Noront.

Personally I'd put the current value closer to $4.75 as that's the kind of conservative number the Wasserman report seemed to indicate.

If FNC has about a $1 based on old aerial surveys and proximity then Noront should get same number for their other anomalities and maybe 50 cents because of their large number of claims. Add in $1 for Windfall and that only leaves $2.25 valuation on what they've found to date, which is probably low given the assay results.

 Buying Noront anywhere under $4.50 for a one month hold seems fairly sensible as maybe a 50 cent downside and $1.50 upside. Maybe will take 2 months to see upside.